Casitas-B-lineage lymphoma protein-b (Cbl-b) is an adaptor protein and RING finger domain-type E3 ubiquitin (Ub) ligase, and has been shown to be important for the maintenance of a balance between immunity and tolerance. Previously, we demonstrated that CD28 costimulation potentiates TCR-induced Cbl-b ubiquitination and degradation, whereas CTLA-4-B7 interaction is required for Cbl-b re-expression. These observations indicate that CD28 and CTLA-4 tightly regulate Cbl-b expression which is critical for establishing the threshold for T cell activation and tolerance. In strong support of this notion, Cbl-b-/- T cells are resistant to anergy induction in vitro and in vivo. Indeed, Cbl-b-/- mice are highly susceptible to autoimmunity. Further studies reveal that Cbl-b not only down- regulates T cell activation, but also selectively inhibits T helper 2 (Th2) differentiation and allergic airway inflammation. Intriguingly, Cbl-b favors peripheral conversion of naove CD4? T cells into CD4???? Tregs (iTregs) in vitro. Although Cbl-b-/- CD4? naturally-occurring Tregs (nTregs) display normal suppressive activity in vitro, Cbl-b-/- CD4? effector T cells (Teffs) are resistant to regulation by nTregs which is possibly due to increased production of IL-4. At the molecular levels, Cbl-b selectively associates with Stat-6, an important transcription factor involved in Th2 cell differentiation, upon IL-4 ligation and may inhibit Th2 differentiation by targeting Stat-6 for degradation. These processes are heightened in the TCR signaling. Furthermore, Cbl-b facilitates iTreg generation by inhibiting PI3-K/Akt activation. Based upon the above data, we hypothesize that Cbl-b targets Stat-6 for ubiquitination and facilitate iTreg generation, thus inhibiting Th2 responses and allergic airway inflammation. To test this hypothesis, we will investigate: 1) whether Cbl-b inhibits Th2 responses by targeting Stat-6 for ubiquitination, thus suppressing alleric airway inflammation;and 2) whether and how Cbl-b regulates the development of iTregs in vivo, therefore modulating Th2 responses and allergic airway inflammation.
The specific aims of this proposal will address fundamental question: how does Cbl-b regulate its target substrates/pathways related to its biological functions. A better understanding of cellular and molecular mechanisms of Cbl-b biological functions may lead to potential therapeutic approaches for autoimmune diseases and allergic asthma.

Public Health Relevance

Cbl-b is an E3 ubiquitin ligase which is responsible for targeting unwanted proteins for degradation, and hence prevents the accumulation of these unwanted proteins. Mice lacking Cbl-b display hyper-activity of their T and B lymphocytes and are highly susceptible to autoimmunity and asthma induction. We are interested in further characterizing whether and how Cbl-b regulates its substrate proteins affecting its biological functions including T helper 2 cell differentiation and regulatory T cell development which tune the susceptibility to asthma.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section (HAI)
Program Officer
Davidson, Wendy F
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Medicine
United States
Zip Code
Tang, Juan; Lin, Guoxin; Langdon, Wallace Y et al. (2018) Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity. Front Immunol 9:123
Tang, Rong; Langdon, Wallace Y; Zhang, Jian (2018) Regulation of immune responses by E3 ubiquitin ligase Cbl-b. Cell Immunol :
Yin, Jinghua; Zhang, Jian; Lu, Qianjin (2017) The role of basic leucine zipper transcription factor E4BP4 in the immune system and immune-mediated diseases. Clin Immunol 180:5-10
Xiao, Yun; Tang, Juan; Guo, Hui et al. (2016) Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nat Med 22:906-14
Yang, Lifen; Qiao, Guilin; Hassan, Yassir et al. (2016) Program Death-1 Suppresses Autoimmune Arthritis by Inhibiting Th17 Response. Arch Immunol Ther Exp (Warsz) 64:417-23
Xiao, Yun; Qiao, Guilin; Tang, Juan et al. (2015) Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation. J Immunol 195:4218-27
Zhao, Yixia; Guo, Hui; Qiao, Guilin et al. (2015) E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+ Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination. J Immunol 194:1639-45
Zhao, Yixia; Lei, Minxiang; Wang, Zhaoyuan et al. (2014) TCR-induced, PKC-?-mediated NF-?B activation is regulated by a caspase-8-caspase-9-caspase-3 cascade. Biochem Biophys Res Commun 450:526-31
Liu, Qingjun; Zhou, Hong; Langdon, Wallace Y et al. (2014) E3 ubiquitin ligase Cbl-b in innate and adaptive immunity. Cell Cycle 13:1875-84
Sano, Masaki; Sasaki, Takeshi; Hirakawa, Satoshi et al. (2014) Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm. PLoS One 9:e89830

Showing the most recent 10 out of 19 publications